Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry

Ann Rheum Dis. 2016 Apr;75(4):785-6. doi: 10.1136/annrheumdis-2015-208490. Epub 2015 Dec 23.

¹ Department of Rheumatology, Copenhagen University Hospital Herlev and Gentofte, Hellerup, Denmark.
² The Danish Multiple Sclerosis Registry, Neuroscience Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark Department of Neurology, The Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
³ National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
⁴ Department of Neurology, The Danish Multiple Sclerosis Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
⁵ Department of Rheumatology, Frederiksberg Hospital, Frederiksberg, Denmark.

No abstract available

Keywords: Ankylosing Spondylitis; Anti-TNF; Rheumatoid Arthritis.

Publication types